 Liminal BioSciences Inc. Nasdaq TSX: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company today announced the voting results from its Annual General and Special Meeting of Shareholders AGM held virtually on June 8, 2020. A total of 20,352,943 common shares were voted, representing 86.90 of the votes attached to the issued and outstanding common shares of Liminal BioSciences. 